Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Herbal extract may help treat certain types of hair loss.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Exosomes from certain stem cells can fight hair loss by promoting hair growth and maintaining the growth phase of hair.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Acanthus ebracteatus extract may help prevent hair loss.

Adipose-derived stem cells may help treat hair loss.

Finasteride may cause depression and affect brain and gut health in male rats.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

The 3D scaffold helped maintain hair cell traits and could improve hair loss treatments.

Melatonin helps reduce aging signs in human eyelid skin.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Eating a high-fat fish oil diet caused mice to lose hair due to a specific immune cell activity in the skin linked to a protein called E-FABP.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Psoriatic alopecia is a challenging hair loss condition linked to psoriasis, needing better diagnosis and personalized treatments.

A new treatment using valproic acid helps regrow hair safely.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Aging disrupts skin repair and stress responses, but exercise-related IL-15 improves wound healing and skin health in older skin.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.